Head-to-head · Cost-Efficiency Index
Human+ vs Neo Soma Healthcare
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Human+
Cost-first shoppers who want pharmacy-wholesale pricing via a flat membership, in any state.
Visit Human+Neo Soma Healthcare
Shoppers who read past the first-month price to the site's own stated ongoing rate.
Visit Neo Soma HealthcareThe verdict
Human+ and Neo Soma Healthcare tie on the Cost-Efficiency Index at 58/100, so neither wins outright on the numbers. For most shoppers we'd start with Human+ (ranked #287, a hair above #291) — Cost-first shoppers who want pharmacy-wholesale pricing via a flat membership, in any state. But Neo Soma Healthcare is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Human+.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Human+ | Neo Soma Healthcare |
|---|---|---|
| Cost-Efficiency Index | 58/100 | 58/100 |
| Semaglutide / mo | Not disclosed | $199/mo (1.00 mg dose, compounded) |
| Tirzepatide / mo | Not disclosed | $330/mo (2.5 mg dose, compounded) |
| Semaglutide / yr (modeled) | — | $2,388 |
| Tirzepatide / yr (modeled) | — | $3,960 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #287 | #291 |
Human+
58/100Where the value is
- Cost-transparent model: a flat monthly membership with prescriptions billed at pharmacy-wholesale cost instead of marked up
- Available via telehealth in all 50 states
- Filled by US 503A compounding pharmacies and reviewed by board-certified US-licensed clinicians
The tradeoffs
- Specific GLP-1 medications and pricing are not published — you only see them after starting the intake
- Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
Neo Soma Healthcare
58/100Where the value is
- LegitScript verification badge present on the homepage
- Publishes the FDA compounded-medication disclaimer clearly
- Unusually transparent about the semaglutide step-up — the site itself states '$99 for your first month, $199/month thereafter' rather than burying it
The tradeoffs
- The $99 semaglutide headline is a one-time first-month price; $199/month is the real ongoing cost
- Tirzepatide's $330 'Initial Purchase' has no disclosed reorder/thereafter price anywhere on the site — unclear if it recurs at $330 or steps up like semaglutide does
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.